HSA Product

GAVISCON LIQUID

Product approved by Health Sciences Authority (SG)

Basic Information

Product Name

GAVISCON LIQUID

Dosage Form

SUSPENSION

Regulatory Information

Approval Number

SIN09494P

Approval Date

September 13, 1997

Forensic Classification

General Sale List

Drug Type

Therapeutic

Route of Administration

ORAL

Record Created

August 10, 2023

Last Updated

June 3, 2025

ATC Business ID

XA02BX13

Company Information

ManufacturerRECKITT BENCKISER HEALTHCARE (UK) LTD

Registrant

RECKITT BENCKISER (SINGAPORE) PTE LTD

Licence Holder

RECKITT BENCKISER (SINGAPORE) PTE LTD

Active Ingredients

CALCIUM CARBONATE

Strength: 160 mg/10 ml

SODIUM BICARBONATE

Strength: 267 mg/10 ml

SODIUM ALGINATE

Strength: 500 mg/10 ml

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy